First Issued GMP Certificates and Refusals in 2026
January 2026 was marked by high regulatory activity: the...
High Aseptics: R-Opra Launches Complex Oncology Drug Production in Moscow
The Moscow-based R-Opra plant (part of the R-Pharm Group)...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Microgen has registered a new vaccine for children against tick-borne encephalitis in Belarus
The children's vaccine Encevir Neo for the prevention of...
Solopharm has launched a new plant for the production of soft dosage forms
Solopharm, one of the leading pharmaceutical manufacturers in Russia,...
American-Style “Divorce”: US Officially Exits WHO, Leaving Debts and Global Risks Behind
January 22, 2026, will go down in history as...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides
2026 marks not just the arrival of new therapies,...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
Large-Scale Deregistration: 85 Drugs and Substances Excluded from State Register
On January 20, 2026, the Ministry of Health of...
Green Corridor for Veterinary Vaccines: Ministry of Agriculture Simplifies Market Entry
The Ministry of Agriculture of the Russian Federation has...
Important changes in the conduct of pharmaceutical inspections of veterinary manufacturers in accordance with the EAEU Rules
At the end of last year, the third version...
The Mathematics of Sovereignty: EEC Approves Points-Based Procurement System for Pharma
On January 1, 2026, the pharmaceutical market of the...
The “BSVC” continues to conduct pharmaceutical inspections of foreign veterinary medicines manufacturers
The Belarusian State Veterinary Center (the "BSVC") is staffed...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures
OSE Immunotherapeutics SA today announces that the Company is...
AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug...
First Issued GMP Certificates and Refusals in 2026
January 2026 was marked by high regulatory activity: the...
High Aseptics: R-Opra Launches Complex Oncology Drug Production in Moscow
The Moscow-based R-Opra plant (part of the R-Pharm Group)...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Microgen has registered a new vaccine for children against tick-borne encephalitis in Belarus
The children's vaccine Encevir Neo for the prevention of...
Solopharm has launched a new plant for the production of soft dosage forms
Solopharm, one of the leading pharmaceutical manufacturers in Russia,...
American-Style “Divorce”: US Officially Exits WHO, Leaving Debts and Global Risks Behind
January 22, 2026, will go down in history as...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides
2026 marks not just the arrival of new therapies,...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
Large-Scale Deregistration: 85 Drugs and Substances Excluded from State Register
On January 20, 2026, the Ministry of Health of...
Green Corridor for Veterinary Vaccines: Ministry of Agriculture Simplifies Market Entry
The Ministry of Agriculture of the Russian Federation has...
Important changes in the conduct of pharmaceutical inspections of veterinary manufacturers in accordance with the EAEU Rules
At the end of last year, the third version...
The Mathematics of Sovereignty: EEC Approves Points-Based Procurement System for Pharma
On January 1, 2026, the pharmaceutical market of the...
The “BSVC” continues to conduct pharmaceutical inspections of foreign veterinary medicines manufacturers
The Belarusian State Veterinary Center (the "BSVC") is staffed...
Good AI Practice: EMA and FDA Establish 10 Global Principles
Global regulators are setting a unified standard for the...
Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation
Eli Lilly and NVIDIA have announced a major partnership...
OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform
OpenAI has officially announced its expansion into the healthcare...
OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures
OSE Immunotherapeutics SA today announces that the Company is...
AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug...
PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
American-Style “Divorce”: US Officially Exits WHO, Leaving Debts and Global Risks Behind
January 22, 2026, will go down in history as...
“From Extensive Growth to Innovation”: Ministry of Industry and Trade Announced a Paradigm Shift in Pharma Development
On January 21, 2026, at a meeting between the...
Scaling Up: Pharmasyntez-Nord Invests Over 25 Billion Rubles in New Plant Phase
The pharmaceutical cluster of Russia's Northern Capital is set...
Large-Scale Deregistration: 85 Drugs and Substances Excluded from State Register
On January 20, 2026, the Ministry of Health of...
Newsletter
Get important news delivered directly to your inbox and stay connected!
© PHARMPROM 2026